Literature DB >> 16827898

Mannan derivatives induce phenotypic and functional maturation of mouse dendritic cells.

Kuo-Ching Sheng1, Dodie S Pouniotis, Mark D Wright, Choon Kit Tang, Eliada Lazoura, Geoffrey A Pietersz, Vasso Apostolopoulos.   

Abstract

Mannan, a polysaccharide isolated from yeast binds to C-type lectins of the mannose receptor family, expressed by antigen-presenting cells (APCs) including dendritic cells (DCs) and macrophages. As these receptors mediate endocytosis, they have been targeted with ligands to deliver antigens into APCs to initiate immune responses. Immunization with tumour antigen MUC1 conjugated to oxidized mannan (OM) or reduced mannan (RM) induced differential immune responses in mice, and only mice immunized with OM-MUC1 elicited strong MUC1-specific cytotoxic T lymphocyte responses and protected mice from a MUC1 tumour challenge. In this study, the adjuvant effect of mannan and its derivatives including OM and RM, in comparison to lipopolysaccharide, on DCs were investigated. Mannan, OM and RM were capable of stimulating mouse bone marrow-derived DC in vitro, eliciting enhanced allogeneic T-cell proliferation and enhancing OTI/OTII peptide-specific T-cell responses. Injection of mice with mannan, OM and RM induced a mature phenotype of lymph node and splenic DCs. Analysis by reverse transcription-polymerase chain reaction indicated that Manna, OM and RM also stimulated up-regulation of inflammatory cytokines including interleukin-1beta and tumour necrosis factor-alpha, and differential T helper 1 (Th1)/Th2 cytokines. Subsequent experiments demonstrated that activation of DCs was Toll-like receptor-4-dependent. The data presented here, together with evidence reported previously on OM and RM in induction of immune responses in vivo, suggest that OM and RM exert a dual capacity to target antigen to APCs as well as mature DCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16827898      PMCID: PMC1782308          DOI: 10.1111/j.1365-2567.2006.02384.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  53 in total

1.  Generation and functional characterization of mouse monocyte-derived dendritic cells.

Authors:  M W Schreurs; A A Eggert; A J de Boer; C G Figdor; G J Adema
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

Review 2.  Generation of cellular immune responses to antigenic tumor peptides.

Authors:  G A Pietersz; V Apostolopoulos; I F McKenzie
Journal:  Cell Mol Life Sci       Date:  2000-02       Impact factor: 9.261

3.  MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines.

Authors:  B Acres; V Apostolopoulos; J M Balloul; D Wreschner; P X Xing; D Ali-Hadji; N Bizouarne; M P Kieny; I F McKenzie
Journal:  Cancer Immunol Immunother       Date:  2000-01       Impact factor: 6.968

4.  Cytokine production from murine CD4 and CD8 cells after mannan-MUC1 immunization.

Authors:  C J Lees; V Apostolopoulos; I F McKenzie
Journal:  J Interferon Cytokine Res       Date:  1999-12       Impact factor: 2.607

5.  CD4 and CD8 expression by dendritic cell subtypes in mouse thymus and spleen.

Authors:  D Vremec; J Pooley; H Hochrein; L Wu; K Shortman
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

6.  Ex vivo targeting of the macrophage mannose receptor generates anti-tumor CTL responses.

Authors:  V Apostolopoulos; N Barnes; G A Pietersz; I F McKenzie
Journal:  Vaccine       Date:  2000-07-15       Impact factor: 3.641

7.  The effect of T1 and T2 cytokines on the cytotoxic T cell response to mannan-MUC1.

Authors:  C J Lees; V Apostolopoulos; B Acres; C S Ong; V Popovski; I F McKenzie
Journal:  Cancer Immunol Immunother       Date:  2000-02       Impact factor: 6.968

Review 8.  Toll-like receptors as key mediators in innate antifungal immunity.

Authors:  Alexander Roeder; Carsten J Kirschning; Rudolf A Rupec; Martin Schaller; Günther Weindl; Hans Christian Korting
Journal:  Med Mycol       Date:  2004-12       Impact factor: 4.076

9.  Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway.

Authors:  V Apostolopoulos; G A Pietersz; S Gordon; L Martinez-Pomares; I F McKenzie
Journal:  Eur J Immunol       Date:  2000-06       Impact factor: 5.532

Review 10.  LPS, TLR4 and infectious disease diversity.

Authors:  Samuel I Miller; Robert K Ernst; Martin W Bader
Journal:  Nat Rev Microbiol       Date:  2005-01       Impact factor: 60.633

View more
  35 in total

1.  β-Galactomannan and Saccharomyces cerevisiae var. boulardii modulate the immune response against Salmonella enterica serovar Typhimurium in porcine intestinal epithelial and dendritic cells.

Authors:  Roger Badia; M Teresa Brufau; Ana Maria Guerrero-Zamora; Rosil Lizardo; Irina Dobrescu; Raquel Martin-Venegas; Ruth Ferrer; Henri Salmon; Paz Martínez; Joaquim Brufau
Journal:  Clin Vaccine Immunol       Date:  2012-02-01

2.  Immunoglobulins drive terminal maturation of splenic dendritic cells.

Authors:  Natalia Zietara; Marcin Łyszkiewicz; Jacek Puchałka; Gang Pei; Maximiliano Gabriel Gutierrez; Stefan Lienenklaus; Elias Hobeika; Michael Reth; Vitor A P Martins dos Santos; Andreas Krueger; Siegfried Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2013-01-23       Impact factor: 11.205

3.  Rapid spread of mannan to the immune system, skin and joints within 6 hours after local exposure.

Authors:  C Hagert; R Siitonen; X-G Li; H Liljenbäck; A Roivainen; R Holmdahl
Journal:  Clin Exp Immunol       Date:  2019-02-27       Impact factor: 4.330

Review 4.  Carbohydrate-based immune adjuvants.

Authors:  Nikolai Petrovsky; Peter D Cooper
Journal:  Expert Rev Vaccines       Date:  2011-04       Impact factor: 5.217

5.  Mannan-mediated gene delivery for cancer immunotherapy.

Authors:  Choon K Tang; Jodie Lodding; Gabriela Minigo; Dodie S Pouniotis; Magdalena Plebanski; Anja Scholzen; Ian F C McKenzie; Geoffrey A Pietersz; Vasso Apostolopoulos
Journal:  Immunology       Date:  2007-03       Impact factor: 7.397

6.  Mannan-modified adenovirus encoding VEGFR-2 as a vaccine to induce anti-tumor immunity.

Authors:  Jie Zhang; Ying Wang; Yang Wu; Zhen-Yu Ding; Xin-Mei Luo; Wu-Ning Zhong; Jie Liu; Xiang-Yu Xia; Guo-Hua Deng; Yao-Tiao Deng; Yu-Quan Wei; Yu Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2014-02-14       Impact factor: 4.553

Review 7.  Plant-derived polysaccharides activate dendritic cell-based anti-cancer immunity.

Authors:  Siambi Kikete; Li Luo; Beitian Jia; Li Wang; Gregory Ondieki; Yuhong Bian
Journal:  Cytotechnology       Date:  2018-03-19       Impact factor: 2.058

8.  Complement drives Th17 cell differentiation and triggers autoimmune arthritis.

Authors:  Motomu Hashimoto; Keiji Hirota; Hiroyuki Yoshitomi; Shinji Maeda; Shin Teradaira; Shuji Akizuki; Paz Prieto-Martin; Takashi Nomura; Noriko Sakaguchi; Jörg Köhl; Birgitta Heyman; Minoru Takahashi; Teizo Fujita; Tsuneyo Mimori; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

Review 9.  The role of the IL-12 cytokine family in directing T-cell responses in oral candidosis.

Authors:  Xiao-Qing Wei; Helen Rogers; Michael A O Lewis; David W Williams
Journal:  Clin Dev Immunol       Date:  2010-10-24

10.  Altered peptide ligands of myelin basic protein ( MBP87-99 ) conjugated to reduced mannan modulate immune responses in mice.

Authors:  Maria Katsara; Elizabeth Yuriev; Paul A Ramsland; Theodore Tselios; George Deraos; Athanasios Lourbopoulos; Nikolaos Grigoriadis; John Matsoukas; Vasso Apostolopoulos
Journal:  Immunology       Date:  2009-12       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.